Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical… EP News Bureau Apr 16, 2026 The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData Global Data May 17, 2024 According to GlobalData, more than 190 million people currently live with type 2 diabetes and/or obesity in 7MM, and the numbers…
